Select Page
Transparency is needed to reap the full benefits of the EU’s investment in its Vaccines Strategy, say health NGOs

Transparency is needed to reap the full benefits of the EU’s investment in its Vaccines Strategy, say health NGOs

by | Sep 18, 2020 | COVID-19, Universal Access and Affordable Medicines | Latest Developments

The COVID-19 crisis represents an unprecedented challenge for societies in the European Union as well as at a global level. The European vaccines strategy’s Advance Purchase Agreements (APAs) mechanism has been used by the EU to procure vaccines for COVID-19. We...
Public health must be the leading priority of Europe’s pharmaceutical sector

Public health must be the leading priority of Europe’s pharmaceutical sector

by | Jul 13, 2020 | Universal Access and Affordable Medicines | Latest Developments, Universal Access and Affordable Medicines | Publications

The EU must ensure access to affordable and quality medicines in Europe whilst guaranteeing everyone’s right to a healthy and sustainable environment. Human medicine is not an ordinary commodity – public interest and public health should prevail as leading...
What lies ahead for health under the German Presidency?

What lies ahead for health under the German Presidency?

by | Jul 9, 2020 | #EU4Health, Clean Air | Latest Developments, COVID-19, Digital Health | Latest Developments, Europe and Health, Health Inequalities, Universal Access and Affordable Medicines | Latest Developments

Germany assumed the Presidency of the Council of the European Union from 1 July, but in quite different circumstances from what was originally foreseen, with the response to tackling COVID-19, and its health, economic and social consequences being the defining issue...